You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

News

Restated financial information January-December 2017

April 13 2018, Gothenburg, Sweden

Restated financial information January-December 2017

From January 1, 2018, Getinge is reporting a new business area, Life Science, which was previously presented in Surgical Workflows. As a result of this change, Getinge publishes restated financial information for 2017 with the information for Surgical Workflows and Life Science adjusted for this change.

 Restated segment information 2017

Order intake, SEK M Quarter   1 Quarter   2  Quarter   3  Quarter   4 Jan-Dec
Acute Care   Therapies 2,975 3,109 2,845 3,454 12,383
Life   Science 552 464 427 568 2,011
Surgical Workflows 1,852  1,950  2,430  2,602  8,834 
Total 5,379 5,523 5,702  6,624 23,228

 

Net sales, SEK M Quarter   1 Quarter   2  Quarter   3  Quarter   4 Jan-Dec
Acute Care   Therapies 2,825 3,094 2,621 3,661 12,201
Life   Science 461 406 487 593 1,947
Surgical   Workflows 1,525  1,869  1,836  3,117  8,347 
Total 4,811 5,369 4,944 7,371 22,495

 

EBITDA,   SEK M Quarter   1 Quarter   2 Quarter   3 Quarter   4 Jan-Dec
Acute Care Therapies 714 318 622 873 2,527
Life Science 118 79 117 119 433
Surgical   Workflows -36  139  101  504  708 
Common Group functions and Other
  (incl. eliminations)
-48  -49  -64  -48  -209 
Total 748 487 776 1,448 3,459



EBITA,   SEK M
Quarter   1 Quarter   2   Quarter   3    Quarter 4  Jan-Dec
Acute Care Therapies 547 146 414 578 1,685
Life Science 102 64 99 102 367
Surgical   Workflows -143  31  -3  355  240 
Common Group functions and Other   (incl. eliminations) -49  -50  -65  -49  -213 
Total 457 191 445 986 2,079

 

Operating   profit (EBIT), SEK M Quarter   1 Quarter   2  Quarter   3  Quarter   4 Jan-Dec
Acute Care Therapies 405 12 271 443 1,131
Life Science 102 64 96 102 364
Surgical   Workflows -156  16  2  349  211 
Common Group functions and Other   (incl. eliminations) -49  -50  -65  -49  -213 
Total 302 42 304 845 1,493


Reclassification between cost of goods sold and administrative costs for the first two quarters 2017

In addition to the above recalculated information, reclassification of costs (with no impact on operating profit) has occurred between cost of goods sold and administrative costs, reflecting organizational changes in Quality and IT in 2017. The reclassification means that cost of goods sold decrease by SEK 50 M in the first quarter of 2017 and by SEK 60 M in the second quarter of 2017. Administrative costs increase with the corresponding amount for the respective quarter. For the full year 2017, the reclassifications mean that cost of goods sold decrease by SEK 110 M and administrative costs increase by the corresponding amount.


For more information, contact

Lars Mattsson
Head of Investor Relations
Phone: +46 (0)10-335 0043
E-mail: lars.mattsson@getinge.com

Share: